Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Input: Consider Input: Paragraph: The lawsuit marks the first multi-plaintiff trial in the litigation over whether glyphosate, Roundup’s active ingredient, is carcinogenic, and is the first trial outside of California. It is being held in St. Louis, where Monsanto was headquartered before Bayer bought the company in a $63 billion deal in 2018. Three consecutive juries found the company liable for causing cancer with damages of tens of millions of dollars awarded to each plaintiff. Bayer is appealing those verdicts. Court-appointed mediator Ken Feinberg has put the number of Roundup cancer claimants at more than 75,000 while Bayer said the claims it has been served with in court were below 50,000. Bayer’s share price has tumbled since the first verdict in August 2018 but the stock rose 3% on Friday after Bloomberg reported a possible out-of-court settlement with some plaintiffs that could lead to a total payout of about $10 billion. While traders said the market likes the idea of Bayer settling the litigation, some cautioned that the prospect of a comprehensive deal remained uncertain. Analysts have estimated the size of any such settlement at $8-$12 billion. While most plaintiffs’ lawyers have agreed to postpone trials pending negotiations, some have decided to pursue their clients’ day in court. The case in Missouri’s Circuit Court for the 22nd Judicial Circuit of the City of St. Louis is scheduled to last several weeks, with both sides presenting extensive scientific evidence through expert witnesses. Bayer denies all allegations that Roundup or glyphosate causes cancer, saying decades of independent studies have shown the world’s most widely used weed killer to be safe for human use and noting that regulators around the world have approved the product. “At the end of the day, this trial should come down to the weight of the science, and we remain confident in the extensive scientific record and regulatory assessments that support the safety of our glyphosate-based herbicides and that they do not cause cancer,” the company said in a statement. Several court cases have been postponed by both parties in the past to expedite settlement talks. By pursuing the St. Louis trail The Miller Firm LLC, a key player in the litigation, is seeking to increase pressure on Bayer. The case involves the claims of Bryce Batiste from Louisiana, Ann Meeks from Florida, Glen Ashelman from Pennsylvania and Christopher Wade, a St. Louis resident. All four have been diagnosed with non-Hodgkin’s lymphoma, a blood cell cancer that plaintiffs in the litigation allege is caused by Roundup. Some legal experts said Bayer could benefit from a home advantage in the St. Louis trial, where Monsanto has century-old roots. But juries in the city are also known to dole out massive damages awards against large corporations. Claim: Bayer faces fourth U.S. Roundup cancer trial in Monsanto's hometown.

Output: Bayer AG is set to face a fourth U.S. jury trial over allegations that its Roundup weed killer causes cancer, with four cancer patients in the hometown of its agricultural subsidiary Monsanto scheduled to begin making their case on Friday.


Input: Consider Input: Paragraph: "Gov. Andrew M. Cuomo says women in New York state don’t have to worry about new Trump administration rules ending a federal requirement that employers must include birth control coverage in their health insurance plans. The new rules exempt employers from the Obama-era mandate if they have religious or moral reservations to the coverage. But Cuomo said contraception will still be covered in New York state. ""This year, we ensured that whatever happens at the federal level, women in our state will continue to have cost-free access to reproductive health care,"" Cuomo said in a statement. States can set certain insurance standards beyond what the federal government requires. New York state told insurance companies in January they are required to cover birth control and abortion services. That condition still stands, but is Cuomo right that women in New York state are not affected by Trump’s decision? Limits to state regulation State regulations, like the one from January, do not apply to all plans. The state Department of Financial Services regulates everything sold on the state health exchange, called New York State of Health. That includes plans sold to individuals and companies with 100 or fewer employees. The agency says the state’s birth control mandate covers 1.35 million residents in those plans. Health care offered through companies with more than 100 employees is more complicated. Companies that go the traditional route of buying health coverage through an insurance carrier must adhere to the rules. About 2.5 million people in that category are covered by the state’s birth control mandate. But companies that are self-insured, where the employer assumes a large part of the costs, are not regulated by the state, meaning they need not adhere to the state's birth control mandate. About 60 percent of private sector workers in the U.S. who get their health coverage through an employer were enrolled in a self-insured plan in 2015. That’s up from 46 percent in 1996, according to research from the Employee Benefit Research Institute. In New York state, about 54 percent of private sector employees who get health insurance through their employer had a self-insured plan last year, according to the federal Agency for Healthcare Research and Quality. The option is most popular for companies with at least 1,000 employees. Eighty percent of private sector employees at companies that size in New York state are enrolled in a self-insured plan. What about public health insurance? The federal government sets the baseline for what services are covered under Medicaid. Government workers are covered under state regulation, but Medicaid and Medicare enrollees are not.States can add to that list. The list of services covered by Medicaid in New York state goes well beyond the federal standard. New York is one of multiple states where Medicaid covers birth control and abortion services. About a third of the state’s population alone is on Medicaid. Our ruling Cuomo said women in New York state ""will continue to have cost-free access to reproductive health care"" because of an action the state took earlier this year. But not every woman is in an insurance plan regulated by the state. It’s possible a self-insured large employer in New York state could apply for an exemption from the federal birth control mandate. If granted the exemption, the company would not have to provide health coverage for birth control to its employees. Those exemptions are not expected to be widespread, but they are possible. Cuomo’s statement needs clarification." Claim: Women in our state will continue to have cost-free access to reproductive health care

Output: "Cuomo said women in New York state ""will continue to have cost-free access to reproductive health care"" because of an action the state took earlier this year. But not every woman is in an insurance plan regulated by the state. It’s possible a self-insured large employer in New York state could apply for an exemption from the federal birth control mandate. If granted the exemption, the company would not have to provide health coverage for birth control to its employees. Those exemptions are not expected to be widespread, but they are possible. Cuomo’s statement needs clarification."


Input: Consider Input: Paragraph: Officials with Dolphinaris Arizona said the voluntary closure will start Friday and there isn’t an immediate timetable for reopening. They said in a statement that an investigative panel that includes veterinarians, pathologists, water quality experts and animal behavior specialists will assess all aspects of the facility and operations and report their findings and any recommendations. “We hope to find a long term solution for the welfare of our dolphins,” said Dolphinaris general manager Christian Schaeffer de Leon. More than 100 protesters demonstrated Saturday outside the facility located on tribal land near Scottsdale, calling for its closure after a 22-year-old dolphin on loan to Dolphinaris Arizona died last Thursday. Dolphinaris hired an external pathologist to determine the cause of death and said it occurred after the dolphin’s condition began deteriorating and he had difficulty swimming, eating and breathing. Dolphin Quest, the company who loaned out the animal, terminated its contract with Dolphinaris Arizona the day after the death. Two of the facility’s four remaining dolphins are being returned to Dolphin Quest while the other two will be moved to another licensed facility while Dolphinaris Arizona is being evaluated. An 11-year-old dolphin died in December from a chronic illness due to a parasite called Sarcocystis that she had for six years. In May 2018, a 10-year-old dolphin at Dolphinaris died from a bacterial infection. And in September 2017, a 7-year-old dolphin died at the facility from a muscle disease. Calls to the U.S. Department of Agriculture’s animal and plant health inspection service seeking for comment on the Dolphinaris situation weren’t immediately returned Tuesday. Dolphinaris, part of the OdySea In The Desert complex on the Salt River Pima-Maricopa Indian Community near Scottsdale, opened in October 2016. Dolphinaris has additional sites in Mexico. Dolphin Quest operates its own locations in Hawaii and Bermuda. Claim: Arizona facility temporarily closing after 4th dolphin death.


Output: After the death of a fourth dolphin, a Phoenix-area aquatic facility announced Tuesday that it will temporarily close for a reevaluation by an outside panel of experts.